Dergiler / Bağcılar Tıp Bülteni / 2021 / Cilt: 6 - Sayı: 2

Multiple Primary Tumors of the Gastrointestinal Tract: Our Six-year Results

Gastrointestinal Sistemin Çoklu Primer Tümörleri: Altı Yıllık Sonuçlarımız

Sayfa
148–156
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: In terms of GIS tumors, prostate and colon tumors in men and breast tumors in women may be risk factors for the development of MPTs.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Multiple primary tumors (MPTs) are tumors that develop simultaneously or at different times in the same or different organs.
📊
Temel Bulgular & Veri:Genetic instability, gene mutation, immunodeficiency, prolongation of life span with chemotherapy, radiotherapy and target treatments are among the reasons that increase the development of the second primary tumor.
💡
Sonuç & Katkı:Conclusion: In terms of GIS tumors, prostate and colon tumors in men and breast tumors in women may be risk factors for the development of MPTs.
🔬Tür:Araştırma Makalesi
📍Kapsam:2014 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: Multiple primary tumors (MPTs) are tumors that develop simultaneously or at different times in the same or different organs. They are divided into two groups as synchronous and metachronous tumors. Genetic instability, gene mutation, immunodeficiency, prolongation of life span with chemotherapy, radiotherapy and target treatments are among the reasons that increase the development of the second primary tumor. In our study, we aimed to present cases with MPTs accompanying gastrointestinal system (GIS) tumors with clinicopathological features.Method: The cases having the criteria of MPT among the cases diagnosed with primary tumor discussed in the GIS councils of our hospital between 2014 and 2019 were included in our study. Results: A total of 162 cases (4.7%) with a diagnosis of MPT were detected. While 52 of the cases were in the synchronous tumor group and 110 were in the metachronous tumor group. Most of the patients in both groups were male (59.9%). The most common MPT groups observed in men were left colon-prostate and rectum-right colon tumors, and stomach-breast and left colon-breast tumors in women. The second primary tumors accompanying GIS tumors in the synchronous and metachronous tumor groups belonged to the GIS and urogenital system. Survival rates were lower in cases with metachronous tumors than in cases with synchronous tumors, but the intergroup difference was not statistically significant. The survival rate in cases of GIS malignancy originating from the stomach was lower compared to cases with other GIS malignancies with a statistically significant difference. Conclusion: In terms of GIS tumors, prostate and colon tumors in men and breast tumors in women may be risk factors for the development of MPTs.

Abstract

Amaç: Çoklu primer tümörler (ÇPT) eş zamanlı ya da farklı zamanda aynı ya da farklı organlarda gelişen tümörlerdir. Senkron ve metakron tümör olarak iki gruba ayrılmaktadırlar. Genetik instabilite, gen mutasyonu, immün yetmezlik, kemoterapi, radyoterapi ve hedef tedavileri ile yaşam süresinin uzaması ikinci primer tümör gelişimini artıran nedenler arasında sayılmaktadır. Çalışmamızda gastrointestinal sistem (GİS) tümörleri ile birliktelik gösteren ÇPT’li olguları klinikopatolojik özellikleriyle birlikte sunmayı amaçladık. Yöntem: Çalışmamıza 2014-2019 yılları arasında hastanemiz GİS konseylerinde tartışılan primer tümör tanısı almış olgular içinden ÇPT kriterleri taşıyan olgular dahil edildi. Bulgular: ÇPT tanılı 162 olgu (%4,7) saptandı. Olguların 52’si senkron, 110’u metakron tümör grubundaydı. Her iki grupta olguların çoğu erkekti (%59,9). Erkeklerde en sık izlenen çoklu primer tümör grubu sol kolonprostat ve rektum-sağ kolon iken, kadınlarda mide-meme ve sol kolonmemeydi. Senkron ve metakron tümör grubunda GİS tümörlerine eşlik eden ikinci primer tümörler GİS ve ürogenital sisteme aitti. Sağkalım oranları metakron tümörlü olgularda senkron tümörlü olgulara göre daha düşük saptandı, ancak aradaki fark istatistiksel olarak anlamlı değildi. GİS malignitesi mide kaynaklı olgularda sağkalım oranı, diğer GİS malignitesi olan olgularla karşılaştırıldığında daha düşüktü ve istatistiksel olarak anlamlıydı. Sonuç: GİS tümörleri açısından erkeklerde prostat ve kolon, kadınlarda ise meme tümörleri ÇPT gelişimi için risk faktörü olabilir.

🔖

Bu Makaleye Atıf Yap

ERHAN, S. Ş., DİNÇER, S., UYSAL, E., ALEMDAR, A. (2021). Multiple Primary Tumors of the Gastrointestinal Tract: Our Six-year Results. Bağcılar Tıp Bülteni, Cilt: 6 - Sayı: 2, 148–156. https://ajindex.com/articles/351127

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Warren S, Gates O. Multiple primary malignant tumors: A survey of the literature and statistical study. Am J Cancer 1932;9(16):1358- 1414
  2. Campbell LV, Watne AL. Multiple primary malignant neoplasms. Arch Surg 1969;99(3):401-405
  3. Mehdi I, Shah AH, Moona MS, Verma K, Abussa A, Elramih R, et al. Synchronous and metachronous malignant tumours expect the unexpected. J Pak Med Assoc 2010;60(11):905-909
  4. Liu z, Liu C, Guo W, Li S, Bai O. Clinical analysis of 152 cases of multipl primary malignant tumors in 15,398 patients with malignant tumors. Plos One 2015;10(5):e0125754. doi: 10.1371/ journal.pone.0125754
  5. Lv M, Zhang X, Shen Y, Wang F, Yang J, Wang B, et al. Clinical analysis and prognosis of synchronous and metachronous multiple primary malignant tumors. Medicine (Baltimore) 2017;96(17):e6799. doi: 10.1097/MD.0000000000006799
  6. Doğu GG, Yaren A, Taşköylü BY, İşler K, Değirmencioğlu S. Synchronous and metachronous double primary cancer patients: Single center experience. Pamukkale Medical Journal 2012;5(1):1- 4
  7. Aydıner A, Karadeniz A, Uygun K, Tas S, Tas F, Disci R, et al. Multiple primary neoplasms at a single institution: Differences between synchronous and metachronous neoplasms. Am J Clin Oncol 2000;23(4):364-370
  8. Demandante CGN, Troyer DA, Miles TP. Multiple primary malignant neoplasms case report and a comprehensive review of the literature. Am J Clin Oncol 2003;26(1):79-83
  9. Engin K. Cancers in multipl primary sites. Int Surg 1994;79(1):33- 37
  10. Ikubo A, Matsufuji S, Morifuji Y, Koga H, Kobarai T, Kouya N, et al. Clinical features, prognosis, diagnostic approaches and treatment of multipl primary malignancies in the digestive system. Anticancer Res 2019;39(12):6863-6870
  11. Shah BK, Khanal A, Hewett Y. Second primary malignancies in adults with gastric cancer-A US population-based study. Front Oncol 2016;6(82):1-4
  12. Motuzyuk I, Sydorchuk O, Kovtun N, Palian Z, Kostiuchenko Y. Analysis of trends and factors in breast multiple primary malignant neoplasms. Breast Cancer 2018;12: 1178223418759959. doi: 10.1177/1178223418759959 13. Lawniczak M, Gawin A, Jaroszewicz-Heigelmann H, RogozaMateja W, Raszeja-Wyszormirska J, Bialek A, et al. Synchronous and metachronous neoplasms in gastric cancer patients: A 23-year study. W J Gastroenterol 2014;20(23):7480-7487
  13. Ballester V, Cruz-Correa M. How and when to consider genetic testing for colon cancer? Gastroenterol 2018;155(4):955-959
  14. Hayat MJ, Howlader N, Reichman ME, Edwa